Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
A Single-Center, Masked, Randomized Study Comparing Bepreve (Bepotastine Besilate) 1.5% - H1 Specific Antihistamine vs. Alrex (Loteprednol Etabonate) 0.2% - Corticosteroid in Subjects With Moderate to Severe Allergic Conjunctivitis
Status: Enrolling
Updated:  1/18/2013
Eye Car Center, Southern California college of Optometry
mi
from
Fullerton, CA
Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
A Single-Center, Masked, Randomized Study Comparing Bepreve (Bepotastine Besilate) 1.5% - H1 Specific Antihistamine vs. Alrex (Loteprednol Etabonate) 0.2% - Corticosteroid in Subjects With Moderate to Severe Allergic Conjunctivitis
Status: Enrolling
Updated: 1/18/2013
Eye Car Center, Southern California college of Optometry
mi
from
Fullerton, CA
Click here to add this to my saved trials
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients.
Status: Enrolling
Updated:  1/31/2013
Usf Asthma Allergy and Immunology Cru
mi
from
Tampa, FL
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients
Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients.
Status: Enrolling
Updated: 1/31/2013
Usf Asthma Allergy and Immunology Cru
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Bronchodilation Effects of Cetirizine
Assessment of Bronchodilatory Effects of Cetirizine in Adults With Concomitant Allergic Rhinitis and Mild Asthma as Measured by Impulse Oscillometry.
Status: Enrolling
Updated:  2/4/2013
California Allergy and Asthma Medical Group, Inc.
mi
from
Los Angeles, CA
Study of Bronchodilation Effects of Cetirizine
Assessment of Bronchodilatory Effects of Cetirizine in Adults With Concomitant Allergic Rhinitis and Mild Asthma as Measured by Impulse Oscillometry.
Status: Enrolling
Updated: 2/4/2013
California Allergy and Asthma Medical Group, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bioequivalence of Ethylenediamine Dihydrochloride Study
Clinical Evaluation of TRUE Test Ethylenediamine Dihydrochloride Allergen: Bioequivalence of Vehicle Formulations
Status: Enrolling
Updated:  2/22/2013
Dermatology Specialists PSC
mi
from
Louisville, KY
Bioequivalence of Ethylenediamine Dihydrochloride Study
Clinical Evaluation of TRUE Test Ethylenediamine Dihydrochloride Allergen: Bioequivalence of Vehicle Formulations
Status: Enrolling
Updated: 2/22/2013
Dermatology Specialists PSC
mi
from
Louisville, KY
Click here to add this to my saved trials
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%
Status: Enrolling
Updated:  2/27/2013
University of Iowa
mi
from
Iowa City, IA
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%
Status: Enrolling
Updated: 2/27/2013
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
A Phase IV Study Of The Impact Of Vorinostat On Cellular Signaling And Cytokine Production In Cutaneous T-Cell Lymphoma Patients With Pruritus
Status: Enrolling
Updated:  2/27/2013
Boston University
mi
from
Boston, MA
Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
A Phase IV Study Of The Impact Of Vorinostat On Cellular Signaling And Cytokine Production In Cutaneous T-Cell Lymphoma Patients With Pruritus
Status: Enrolling
Updated: 2/27/2013
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Redondo Beach, CA
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Miami, FL
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Naperville, IL
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Naperville, IL
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Mandeville, LA
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Mandeville, LA
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Minneapolis, MN
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Plymouth, MN
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Kansas City, MO
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Plainsboro, NJ
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Plainsboro, NJ
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
New Brunswick, NJ
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
High Point, NC
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Portland, OR
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
Upland, PA
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
Upland, PA
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
San Antonio, TX
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated:  3/22/2013
Clinical Research Facility
mi
from
San Antonio, TX
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (Protocol 008)
Status: Enrolling
Updated: 3/22/2013
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Status: Enrolling
Updated:  4/1/2013
Alcon Call Center
mi
from
Fort Worth, TX
Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis
Status: Enrolling
Updated: 4/1/2013
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Clinical research Center of Alabama
mi
from
Birmingham, AL
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Clinical research Center of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Little Rock Allergy and Asthma Clinical research Center
mi
from
Little Rock, AK
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Little Rock Allergy and Asthma Clinical research Center
mi
from
Little Rock, AK
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
West Coast Clinical Trials
mi
from
Costa Mesa, CA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
West Coast Clinical Trials
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Allergy & Asthma Care Center of So. Cal
mi
from
Long Beach, CA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Allergy & Asthma Care Center of So. Cal
mi
from
Long Beach, CA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Southern California Research
mi
from
Mission Viejo, CA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Southern California Research
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Allergy Associates Medical Group
mi
from
San Diego, CA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Allergy Associates Medical Group
mi
from
San Diego, CA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Allergy & Asthma Associates of Santa Clara Valley Research Cntr
mi
from
San Jose, CA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Allergy & Asthma Associates of Santa Clara Valley Research Cntr
mi
from
San Jose, CA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Storms Clinical Research Institute
mi
from
Colorado Springs, CO
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Storms Clinical Research Institute
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Colorado Allergy and Asthma Centers, PC
mi
from
Denver, CO
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Asthma and Allergy Associates, PC
mi
from
Pueblo, CO
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Asthma and Allergy Associates, PC
mi
from
Pueblo, CO
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Allergy and Asthma Care of Florida
mi
from
Ocala, FL
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Allergy and Asthma Care of Florida
mi
from
Ocala, FL
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Atlanta Allergy and Asthma Clinic
mi
from
Stockbridge, GA
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Atlanta Allergy and Asthma Clinic
mi
from
Stockbridge, GA
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Idaho Allergy
mi
from
Eagle, ID
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Idaho Allergy
mi
from
Eagle, ID
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Sneeze, Wheeze & Itch Associates LLC
mi
from
Normal, IL
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Clinical Research Institute of Indiana
mi
from
Indianapolis, IN
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Clinical Research Institute of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Family Allergy and Asthma Reserach
mi
from
Louisville, KY
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Family Allergy and Asthma Reserach
mi
from
Louisville, KY
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Respiratory Medicine Research Institute of Michigan
mi
from
Ypsilanti, MI
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Respiratory Medicine Research Institute of Michigan
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Clinical Reseacrh Institute
mi
from
Minneapolis, MN
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Clinical Reseacrh Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
The Clinical Research Center
mi
from
St. Louis, MO
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
The Clinical Research Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Clinical Research of the Ozarks
mi
from
Warrensburg, MO
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Clinical Research of the Ozarks
mi
from
Warrensburg, MO
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Midwest Allergy and Asthma Clinic
mi
from
Omaha, NE
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Midwest Allergy and Asthma Clinic
mi
from
Omaha, NE
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
The Asthma And Allergy Center, Pc
mi
from
Papillon, NE
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
The Asthma And Allergy Center, Pc
mi
from
Papillon, NE
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Atlantic Research Center LLC
mi
from
Ocean, NJ
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Atlantic Research Center LLC
mi
from
Ocean, NJ
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Asthma, Sinus & Allergy Centers, LLC
mi
from
Warren, NJ
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Asthma, Sinus & Allergy Centers, LLC
mi
from
Warren, NJ
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
North Carolina Clinical Research
mi
from
Meredith, NC
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
North Carolina Clinical Research
mi
from
Meredith, NC
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Bernstein Clinical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated:  4/12/2013
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis
Status: Enrolling
Updated: 4/12/2013
Allergy, Asthma and clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials